Targeted therapy progress of pheochromocytoma and paraganglioma / 肿瘤研究与临床
Cancer Research and Clinic
;
(6): 518-521, 2020.
Article
in Chinese
| WPRIM
| ID: wpr-872535
ABSTRACT
Pheochromocytoma and paraganglioma are rare neuroendocrine tumors. Because of the abnormal secretion of catecholamine, the risk of disease is high. At present, the choice of drug treatment for these diseases is still controversial. The further understanding of the research has showed that the different molecular subtypes have different carcinogenic mechanism and therapeutic response. And a variety of corresponding targeted drugs have entered the clinical trial stage, showing a certain therapeutic potential. This article reviews the current treatment and the progress of targeted drugs for pheochromocytoma and paraganglioma.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Cancer Research and Clinic
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS